References
- Corti M, Palmero D (2008). Mycobacterium avium complex infection in HIV/AIDS patients. Exp Rev Anti Infect Ther 6, 351–363.
- Inderlied CB, Kemper CA, Bermudez LEM. (1993). The Mycobacterium avium complex. Clin Microbiol Rev 6, 266–310.
- Peloquin CA. (1997). Mycobacterium avium complex infection. Clin Pharmacokinet 32, 132–144.
- Kobashi Y, Matsushima T. (2003). The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern Med 42, 670–675.
- Tomioka H, Sano C, et al. (2002). Antimicrobial activities of clarithromycin, gatiofloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. Int J Antimicrob 19, 139–145.
- Brisseau GF, Kresta A, et al. (1994). Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharide-stimulated macrophages. Antimicrob Agents Chemother 38, 2671–2675.
- Onyeji CO, Nightingale CH, Marangos MN (1994). Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection 22, 338–342.
- Oh Y-K, Nix DE, Straubinger RM (1995). Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Chemother 39, 2104–2111.
- Gupta CM, Haq W (2005). Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections. Methods Enzymol 391, 291–304.
- Samad A, Sultana Y, Aqil M. (2007) Liposomal drug delivery systems: an update review. Curr Drug Deliv 4, 297–305.
- Weaver T, Hall CL, et al. (1996). Assessment of in vivo attachment/phagocytosis by alveolar macrophages. J Immunol Methods 193, 149–156.
- Bridges PA, Taylor KMG (1998). Nebulisers for the generation of liposomal aerosols. Int J Pharm 173, 117–125.
- Desai TR, Hancock REW, Finlay WH (2002). A facile method of delivery of liposomes by nebulization. J Control Release 84, 69–78.
- Vyas SP, Kannan ME (2004). Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 269, 37–49.
- Bridges PA, Taylor KMG (2000). An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm 204, 69–79.
- Elhissi AMA, Kiran K, et al. (2006). Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 58, 887–894.
- Bermudez M, Martinez E, et al. (1999). Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study. Colloids Surf A 158, 59–66.
- Rodrigues C, Gamiero P, Reis , et al. (2001). Derivative spectrophotometry as a tool for the determination of drug partition coefficients in watwr/dimyristoyl-L-α-phosphatidylglycerol (DMPG) liposomes. Biophys Chem 94, 97–106.
- Rodrigues C, Gamiero P, et al. (2003). Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies. Biochim Biophys Acta 1620, 151–159.
- Zaru M, Mourtas S, et al. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67, 655–666.
- Bangham AD, Standish MM, Watkins JC (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13, 238–252.
- Waldrep JC, Arppe J, et al. (1998). Experimental pulmonary delivery of cyclosporine A by liposome aerosol. Int J Pharm 160, 239–249.
- Kumar AKH, Chandra I, et al. (2004). A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine. Indian J Pharmacol 36, 231–233.
- Darwis Y, Kellaway IW (2001). Nebulization of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int J Pharm 215, 113–121.
- Bhavane R, Karathanasis E, Ananth V (2003). Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release 93, 15–28.
- Suarez S, Kazantseva M (2001). The influence of suspension nebulization or instillation on particulate uptake by guinea pig alveolar macrophages. Inhal Toxicol 13, 773–788.
- Desai TR, Tyrrel GJ, et al. (2003). In vitro evaluation of nebulization properties, antimicrobial activity, and regional airways surface liquid concentration of liposomal polymyxin B sulfate. Pharm Res 20, 442–447.
- Lange FC, Hancock REW, et al. (2001). In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. J Pharm Sci 90, 1647–1657.
- Pavelic Z, Skalko-Basnet N, et al. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release 106, 34–43.
- Sweeney LG, Wang Z, et al. (2005). Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm 305, 180–185.
- Terzano C, Allegra L, et al. (2005). Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59, 57–62.
- O’Callaghan C, White J, et al. (2002). The output of flunisolide from different nebulisers. J Pharm Pharmacol 54, 565–569.